Advancements in Nanotechnology for Sepsis Management
Author Information
Author(s): Liu Li, Wang Ting, Li Zheyu, Yan Bingpeng, Tan Ruirong, Zeng Anqi, Ma Wenbo, Zhu Xin, Yin Zhujun, Ma Chunhua
Primary Institution: Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China
Hypothesis
Nanomedicines can improve the management of sepsis through targeted drug delivery and enhanced therapeutic efficacy.
Conclusion
Nanomedicines show significant potential in improving sepsis management by enhancing drug delivery and reducing side effects.
Supporting Evidence
- Nanomedicines can target and control the release of bio-active agents, improving therapeutic efficacy.
- Recent advancements in nanotechnology have shown promise in addressing the limitations of conventional sepsis therapies.
- Nanomaterials can be engineered for specific targeting, enhancing their effectiveness in treating sepsis.
Takeaway
Scientists are using tiny materials called nanomedicines to help treat sepsis better, making medicines work more effectively and with fewer side effects.
Methodology
This review summarizes the preparation and efficacy of various categories of anti-sepsis nanomedicines.
Limitations
The review highlights the need for more attention to safety, regulatory laws, and cost-effectiveness in clinical translation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website